콘텐츠로 건너뛰기
R&D
Platform Technology
Pharmulator
Research Project
Publications
Patents
OUR TEAM
Leadership Team
R&D Team
Advisory Board
COMPANY
Company Overview
History
CI & BI
Partnership
Location & Facility
NEWS
Press Release
Seminars & Events
Community
Notice
CONTACT
Menu
R&D
Platform Technology
Pharmulator
Research Project
Publications
Patents
OUR TEAM
Leadership Team
R&D Team
Advisory Board
COMPANY
Company Overview
History
CI & BI
Partnership
Location & Facility
NEWS
Press Release
Seminars & Events
Community
Notice
CONTACT
Press Release
News
01/22/2021
PharmCADD signed a co-development agreement of novel anticancer drug discovery with KYNOGEN
<View Original Article>
Prev
Previous
PharmCADD will create an innovative AI drug and will be listed on KOSDAQ in March 2022.